Riskpilot← Back to searchSign inGet full accessFrankenius Equity Medtech AB
ABActiveOrg 5594126947BoråsEconomic activity was not specified by tax authority · NACE 0000Est. 20220 employees
Revenue 2024
—
EBITDA margin
—
0% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -990
0% vs 2023
| Revenue | — | — |
| EBITDA | SEK -990 | +0% |
| Net profit | SEK -990 | +0% |
| Total assets | SEK 15K | -6% |
| Equity | SEK 15K | -6% |
| Employees | 0 | — |
Legal name
Frankenius Equity Medtech AB
Org number
5594126947
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
15 december 2022
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av Frankenius, Pål Magnus Jöreteg, Maria Ulrika
Company purpose
Bolaget ska äga och förvalta aktier i noterade bolag samt därmed förenlig verksamhet.
Address
Borås
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | — | — |
| Staff expenses | — | −0 | — | — |
| EBITDA | −8 | −8 | −1 | −1 |
| Depreciation & amort. | −0 | −0 | — | — |
| EBIT | −8 | −8 | −1 | −1 |
| Net financials | — | 0 | — | — |
| Profit before tax | −8 | −8 | −1 | −1 |
| Tax | −0 | −0 | — | — |
| Net profit | −8 | −8 | −1 | −1 |
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 25 | 25 | 16 | 15 |
| Equity | 17 | 17 | 16 | 15 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 8 | 8 | 0 | — |
| Total debt | 8 | 8 | — | — |
EBITDA margin
-99000.0%
This company
15.8%
Market median
-626682% vs market
20222024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20222024
Return on equity
-6.5%
This company
18.4%
Market median
-135% vs market
20222024
Net profit margin
-99000.0%
This company
8.1%
Market median
-1222322% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-12-15 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-12-01 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Chairman | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Frankenius Equity AB
Frankenius Equity Medtech AB Board members of Frankenius Equity Medtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| M H Charlotte Wiberg Larsson | Chairman | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Maria Ulrika Jöreteg | Board of Directors | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Kaj Ulf Morgan Öjerklint | Chairman | 0 companies |
| Pål Magnus Frankenius | Board of Directors | 0 companies |
| Hans Gunnar Jacobson | Board of Directors | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |